Arcutis Biotherapeutics, Inc. (ARQT)
24.50
-0.08
(-0.33%)
USD |
NASDAQ |
Apr 16, 09:38
Arcutis Biotherapeutics Research and Development Expense (Annual) : 77.05M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| ADMA Biologics, Inc. | 4.762M |
| Axsome Therapeutics, Inc. | 182.78M |
| Arcus Biosciences, Inc. | 523.00M |
| Stoke Therapeutics, Inc. | 136.15M |